158 related articles for article (PubMed ID: 21663472)
21. In vitro and ex vivo antiangiogenic activity of Salvia officinalis.
Keshavarz M; Mostafaie A; Mansouri K; Bidmeshkipour A; Motlagh HR; Parvaneh S
Phytother Res; 2010 Oct; 24(10):1526-31. PubMed ID: 20878705
[TBL] [Abstract][Full Text] [Related]
22. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
23. The molecular mechanism of luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cells.
Cai X; Lu W; Ye T; Lu M; Wang J; Huo J; Qian S; Wang X; Cao P
Oncol Rep; 2012 Oct; 28(4):1353-61. PubMed ID: 22825765
[TBL] [Abstract][Full Text] [Related]
24. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
25. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
[TBL] [Abstract][Full Text] [Related]
26. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
27. A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis.
Lin KT; Lien JC; Chung CH; Kuo SC; Huang TF
Eur J Pharmacol; 2010 Mar; 630(1-3):53-60. PubMed ID: 20067787
[TBL] [Abstract][Full Text] [Related]
28. Antiangiogenic effects of melatonin in endothelial cell cultures.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
Microvasc Res; 2013 May; 87():25-33. PubMed ID: 23473980
[TBL] [Abstract][Full Text] [Related]
29. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
30. Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis.
Kim JK; Shin EK; Kang YH; Park JH
J Cell Biochem; 2011 May; 112(5):1384-91. PubMed ID: 21337385
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative and antiangiogenic properties of horse chestnut extract.
Mojžišová G; Mojžiš J; Pilátová M; Varinská L; Ivanová L; Strojný L; Richnavský J
Phytother Res; 2013 Feb; 27(2):159-65. PubMed ID: 22451355
[TBL] [Abstract][Full Text] [Related]
32. Extracellular HSP70 blocks CD40L-induced apoptosis and tubular formation in endothelial cells.
Futagami S; Hiratsuka T; Shindo T; Hamamoto T; Horie A; Ueki N; Kusunoki M; Gudis K; Miyake K; Tsukui T; Sakamoto C
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S222-8. PubMed ID: 19120902
[TBL] [Abstract][Full Text] [Related]
33. Direct effects of fascaplysin on human umbilical vein endothelial cells attributing the anti-angiogenesis activity.
Zheng YL; Lu XL; Lin J; Chen HM; Yan XJ; Wang F; Xu WF
Biomed Pharmacother; 2010 Oct; 64(8):527-33. PubMed ID: 19932581
[TBL] [Abstract][Full Text] [Related]
34. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
36. A novel polyacetylene significantly inhibits angiogenesis and promotes apoptosis in human endothelial cells through activation of the CDK inhibitors and caspase-7.
Wu LW; Chiang YM; Chuang HC; Lo CP; Yang KY; Wang SY; Shyur LF
Planta Med; 2007 Jun; 73(7):655-61. PubMed ID: 17559025
[TBL] [Abstract][Full Text] [Related]
37. Role of human cripto-1 in tumor angiogenesis.
Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
[TBL] [Abstract][Full Text] [Related]
38. LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.
Gao JJ; Xue X; Gao ZH; Cui SX; Cheng YN; Xu WF; Tang W; Qu XJ
Microvasc Res; 2011 Sep; 82(2):122-30. PubMed ID: 21664364
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB.
Grosjean J; Kiriakidis S; Reilly K; Feldmann M; Paleolog E
Biochem Biophys Res Commun; 2006 Feb; 340(3):984-94. PubMed ID: 16410078
[TBL] [Abstract][Full Text] [Related]
40. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]